Tonino Spadano

Superior Complete Response Rate and Progression-Free Survival after Autologous Transplantation with up-Front Velcade-Thalidomide- Dexamethasone Compared with Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma

Michèle Cavo, Paola Tacchetti, Francesca Patriarca et al. · Blood · 2008 · 73 citations

Medicine, Hematology, Oncology +12

A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD Compared to TD.

Michèle Cavo, Paola Tacchetti, Francesca Patriarca et al. · Blood · 2009 · 48 citations

Medicine, Hematology, Pharmacotherapy +16

A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens.

Antonio Palumbo, Michèle Cavo, Maide Cavalli et al. · Blood · 2009 · 22 citations

Medicine, Hematology, Pharmacology +15

Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Induction and Consolidation Therapy Before and After Double Autologous Transplantation In Newly Diagnosed Multiple Myeloma: Results From a Randomized Phase 3 Study

Michèle Cavo, Giulia Perrone, Silvia Buttignol et al. · Blood · 2010 · 12 citations

Medicine, Hematology, Oncology +17

MRD Evaluation By PET/CT According to Deauville Criteria Combined with Multiparameter Flow Cytometry in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients Enrolled in the Phase II Randomized Forte Trial

Elena Zamagni, Cristina Nanni, Francesca Gay et al. · Blood · 2019 · 11 citations

Medicine, Nuclear Medicine, Radiology +16